XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period Of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjustment
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2018     58,546,480          
Beginning balance at Dec. 31, 2018 $ 2,043,913   $ 296,483 $ (24,245) $ 1,288,911 $ 500,660   $ (17,896)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 45,110         45,110    
Other comprehensive income 10,446             10,446
Comprehensive income 55,556              
Cash dividends (12,442)         (12,442)    
Issuance of common stock for stock-based compensation awards (in shares)     87,150          
Issuance of common stock for stock-based compensation awards (787)     2,655 (3,442)      
Stock-based compensation expense 2,637       2,637      
Ending balance (in shares) at Mar. 31, 2019     58,633,630          
Ending balance at Mar. 31, 2019 2,088,877   $ 296,483 (21,590) 1,288,106 533,328   (7,450)
Beginning balance (in shares) at Dec. 31, 2018     58,546,480          
Beginning balance at Dec. 31, 2018 2,043,913   $ 296,483 (24,245) 1,288,911 500,660   (17,896)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 91,735              
Other comprehensive income 18,406              
Comprehensive income 110,141              
Ending balance (in shares) at Jun. 30, 2019     58,297,670          
Ending balance at Jun. 30, 2019 2,119,696   $ 296,483 (33,635) 1,289,356 566,982   510
Beginning balance (in shares) at Dec. 31, 2018     58,546,480          
Beginning balance at Dec. 31, 2018 $ 2,043,913   $ 296,483 (24,245) 1,288,911 500,660   (17,896)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting standards update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member              
Ending balance (in shares) at Dec. 31, 2019     56,855,002          
Ending balance at Dec. 31, 2019 $ 2,125,689 $ (35,099) $ 296,483 (83,189) 1,294,276 617,355 $ (35,099) 764
Beginning balance (in shares) at Mar. 31, 2019     58,633,630          
Beginning balance at Mar. 31, 2019 2,088,877   $ 296,483 (21,590) 1,288,106 533,328   (7,450)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 46,625         46,625    
Other comprehensive income 7,960             7,960
Comprehensive income 54,585              
Cash dividends (12,971)         (12,971)    
Repurchase of shares in connection with stock repurchase program (in shares)     (363,704)          
Repurchase of shares in connection with stock repurchase program (12,938)     (12,938)        
Issuance of common stock for stock-based compensation awards (in shares)     27,744          
Issuance of common stock for stock-based compensation awards 61     893 (832)      
Stock-based compensation expense 2,082       2,082      
Ending balance (in shares) at Jun. 30, 2019     58,297,670          
Ending balance at Jun. 30, 2019 2,119,696   $ 296,483 (33,635) 1,289,356 566,982   510
Beginning balance (in shares) at Dec. 31, 2019     56,855,002          
Beginning balance at Dec. 31, 2019 2,125,689 (35,099) $ 296,483 (83,189) 1,294,276 617,355 (35,099) 764
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 2,008         2,008    
Other comprehensive income 13,737             13,737
Comprehensive income 15,745              
Cash dividends (12,555)         (12,555)    
Repurchase of shares in connection with stock repurchase program (in shares)     (818,886)          
Repurchase of shares in connection with stock repurchase program (24,569)     (24,569)        
Issuance of common stock for stock-based compensation awards (in shares)     104,902          
Issuance of common stock for stock-based compensation awards (1,449)     4,138 (5,587)      
Stock-based compensation expense 2,750       2,750      
Ending balance (in shares) at Mar. 31, 2020     56,141,018          
Ending balance at Mar. 31, 2020 2,070,512   $ 296,483 (103,620) 1,291,439 571,709   14,501
Beginning balance (in shares) at Dec. 31, 2019     56,855,002          
Beginning balance at Dec. 31, 2019 2,125,689 $ (35,099) $ 296,483 (83,189) 1,294,276 617,355 $ (35,099) 764
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 22,138              
Other comprehensive income 15,575              
Comprehensive income 37,713              
Ending balance (in shares) at Jun. 30, 2020     56,181,962          
Ending balance at Jun. 30, 2020 2,082,946   $ 296,483 (102,223) 1,293,033 579,314   16,339
Beginning balance (in shares) at Mar. 31, 2020     56,141,018          
Beginning balance at Mar. 31, 2020 2,070,512   $ 296,483 (103,620) 1,291,439 571,709   14,501
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 20,130         20,130    
Other comprehensive income 1,838             1,838
Comprehensive income 21,968              
Cash dividends (12,525)         (12,525)    
Issuance of common stock for stock-based compensation awards (in shares)     40,944          
Issuance of common stock for stock-based compensation awards (7)     1,397 (1,404)      
Stock-based compensation expense 2,998       2,998      
Ending balance (in shares) at Jun. 30, 2020     56,181,962          
Ending balance at Jun. 30, 2020 $ 2,082,946   $ 296,483 $ (102,223) $ 1,293,033 $ 579,314   $ 16,339